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Abstract 
  
Antibiotics are metabolic by-products of complex biosynthetic pathways in 
microorganisms, some of which are proteins or peptides, known for their 
bactericidal and/or fungicidal effect on microorganisms.  This Antimicrobial 
Peptides (AMP) produced by certain bacteria are toxic for other bacteria or for fungi 
but not for mammalia. The aim of this study was to investigate the antimicrobial 
activity of protein derived from six isolated thermophilic bacteria (113a, 94b, 153, 
104c, 83, 110a). Bacteria was fermented in NB medium with 1% glucose in 55⁰C for 
24 hr. Protein was isolated from cell-free extract by salting out method with 60% 
ammonium sulphate followed by dialysis. Antimicrobial activity was tested by 
growing several pathogenic microbes (Eschericia coli, Staphylococcus aureus, and 
Candida albican) in NA and PDA medium and then layering the papper disk with 
protein extract onto the top of those pathogenic microbes. Protein which exhibits 
antimicrobial activity was shown by the presence of a clear zone around the papper 
disk. The result of this study showed that almost protein derived from six isolated 
thermophilic bacteria demonstrate antimicrobial activity to Eschericia coli, 
Staphylococcus aureus, and Candida albican, except the ones isolated from 
thermophilic bacteria no 104c and 83, which have no antimicrobial effect to  
Eschericia coli. 
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INTRODUCTION 
 
Microorganisms develop various ways to increase their defense against drugs, causing 
what is called as drug resistance. They can transfer their genes horizontally (plasmid, transposon 
and bacteriophages), incorporate the host foreign DNA to their chromosome (in bacteria) and 
cause a mutation on different bacterial locus (Alam M. J. at al., 2013).There is a growing 
incidence of cell resistance against antibiotics, antiviral and antifungi drugs. Indeed, some 
theraputic drugs have shown an inadequacy to cope with medical problems related to this cell 
resistance. Making human body more susceptible towards mutant pathogens that no drugs can 
treat, drug resistance has become a crucial problem around the world (Strobel G and Daisy B, 
2003).    
Nevertheles, some natural products demonstrate great potencies to be developed as 
therapeutic agents to overcome these resistant problems (Fawzy G.A  et al., 2011; Strobel G, et 
al., 2003). A large number of drugs have been developed in medicinal practice from natural 
products. Natural resources, such as plants, microorganisms, vertebrates and invertebrates, are 
valuable source of bioactive compounds (Amador et al. 2003). One of which is bacteria, the 
inexhaustible source of chemical compounds, produce a wide variety of biologically active 
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secondary metabolites. For example is marine bacteria, from which a large number of bioactive 
compounds are developed and nowadays they become essential target for biotechnology 
industry. The bioactive metabolites may be produced as a response to ecological pressures, i.e. 
competition, predation deterrence, and reproduction (Gómez et al., 2010).  
The success and discovery of penicillin has opened such opportunities to utilize 
structurally diverse bioactive agents derived from various microorganisms as antibiotics. 
Thereafter, we have seen the discovery of other antibiotics synthesized from microbial 
metabolites such as erythromycin, streptomycin, amphotericin and polyketides (Phonnok S, et 
al., 2010). The antimicrobial peptides, produced by many kinds of microorganism like bacteria, 
are involved in innate immunity, representing host deffence effector molecules. However, there 
should be a great awareness that there are principal differences between microbial and 
mammalian cells that may represent distinct targets for antimicrobial peptides.  
Moreover, the development of antifungal peptides from bacteria as therapeutic agent 
also provides a great challenge. Hospital reports anywhere has stated that the fourth most 
common cause of nosocomial infection is now the major human fungal pathogen Candida 
albicans. Mortality rates associated with systemic fungal infection are close to 50 %, with rates 
reaching 100 % for some fungal pathogens in the developing world. In clinical practice, the 
current applied antifungal treatments seems fail because several reasons such as enormous toxic 
side effects, poor efficacy, and drug resistance. Until now, most research only focuses on the 
activity of antimicrobial peptides against bacteria. Although some study demonstrated that 
several antimicrobial peptides specifically target fungal cells and are not active against bacteria. 
Others with broader specificity often have different mechanisms of action against bacteria and 
fungi. Therefore, understanding the mechanism of anti fungal actions to investigate the potential 
use of innate immunity peptides as novel therapeutics against fungi is of great interest for 
human (van der Weerden et al., 2013).  
The objective of this study was to investigate the antibacterial and antifungal activities 
of the protein extracelullar extracts derived from six isolated thermophilic bacteria of Gendol 
river after Merapi eruption in 2010.  
 
RESEARCH METHOD 
 
This study was designed as an exploration experiment. The objects were thermophilic 
bacteria isolated from water and mud of Gendol river, Merapi volcano. We synthesized protein 
from cell-free extracts of these bacteria and use it to test its effects against some pathogens 
which were E coli, Staphylococcus aureus and Candida albicans. We employed materials and 
tools as follow: isolated thermophilic bacteria, isolated pathogenic bacteria and fungi, microbial 
test disk blank, medium NB, NA, PDA, PD Broth, aquades, polyachrylamid, SDS, protein 
marker, ammonium sulfat, glucose 1%, LAF, Flash culture bottle, conicle tubes, pipet, ose, petri 
dish, drygalski, micropipet, blue tip, tissue, erlenmeyer tubes, incubator, analytic balancer, 
sentrifuge, electrophoresis tank, dialysis pocket, spectrofotometer, and refrigerator.  
Antibiotic production 
Preparation 
The inoculum was grown on a 100 ml of Nutrien Broth medium. Briefly, the medium was 
prepared in a 250 ml of erlenmeyer tube and autoclaved at 121°C and 15 psi pressure for 15 
mins. The thermophilic bacteria was grown on a slope nutritious agar and incubated at a 
temperature of 55°C for 24 hours. Reisolation was performed to create a new culture, using a 
sterile ose to incubate again at the same temperature for another 24 jam. Then, it was moved to 
NB medium by using 1 ose.  
Batch fermentation 
A 1% glucose in 1,5 L of aquadest was added to NB media, creating a production medium then 
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was sterilized in a 250 ml Erlenmeyer. The 10% inokulum was put onto the medium and 
incubated again at 55°C for another 24 hours. Then, the sample was removed into a 15 mL of 
conicle tube and centrifuged for 30 minutes at 3000 rpm to get a cell-free supernatant.  
Isolating and Purifying Protein 
The protein from the supernatant was collected by using a 60% of ammonium sulfat, followed 
by dialysis to get rid of the remnant ammonium sulfat. The protein profile was then checked 
with SDS PAGE. 
The Antimicrobial Test  
1. Antifungal effect 
A series of dilution was performed on the protein to get concentration of 100%, 80%, 60%, 40% 
and 20%. Afterward, a 10 µl sample was dipped onto a 5 mm paper disk. Meanwhile, the sterile 
20 mL of PDA was kept hardened to be inoculated with a 100 µl of Candida albicans and put 
aside for 30-60 minutes. Afterwards, the previous paper disk with protein was layered and we 
waited for another 24 hours at a temperature of 37
o
C to measure the barrier zone.  
2. Antibacterial effect 
The same preparation as above, only this time the protein in paper disk was tested on a 20 mL 
of sterile NA inoculated with 100 µl of E coli and Staphylococcus aureus. The same 
measurement as above was also employed.  
 
RESULTS AND DISCUSSION 
 
The results showed that each protein demonstrates different effects against the three 
tested pathogens as seen in Table 1. These data showed that protein derived from each isolate 
have various anti bacterial and anti fungal actions. However, the protein derived from isolate 
number D83 dan D104c showed no anti bacterial effect against E coli, while protein from other 
isolate demonstrated antimicrobial activity with different clear zone result. The result of 
antimicrobial activity derived from 6 isolated thermophlic bacteria was presented in these 
figures number 1 to 6 below. 
 
Table 1. Antimicrobial effect of extracelluar protein derived from the 6 isolated thermophilic 
bacteria 
Isolate 
Number 
Protein 
concentration 
(μg/μl) 
Staphylococcus aureus Eschericia coli Candida albican 
Average 
clear zone 
(mm) 
Average 
inhibition 
zone (mm) 
Average 
clear 
zone 
(mm) 
Average 
inhibition 
zone 
(mm) 
Average 
clear 
zone 
(mm) 
Average 
inhibition 
zone 
(mm) 
113a 
0,94 7,2±0,2 2,2 6,2±0,1 1,2 8,4±0,6 3,4 
0,75 7,1±0,4 2,1 6,5±0,2 1,5 8,3±0,3 3,3 
0,56 7,0±0,4 2,0 6,3±0,2 1,3 8,2±0,5 3,2 
0,38 6,6±0,1 1,6 6,2±0,1 1,2 7,8±0,1 2,8 
0,19 6,5±0,2 1,5   7,1±0,1 2,1 
94b 
0,85 7,2±0,2 2,2 8,0±0,2 3,0 8,8±0,6 3,8 
0,68 6,9±0,1 1,9   8,7±0,1 3,7 
0,51 7,0±0,2 2,0   7,7±0,1 2,7 
0,34 6,7±0,3 1,7   7,0±0,1 2,0 
0,17 6,5±0,1 1,5   7,0±0,3 2,0 
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153 
0,67 7,2±0,3 2,2 6,9±0,1 1,9 9,9±0,1 4,9 
0,54 6,6±0,4 1,6 7,4±0,1 2,4 9,2±0,5 4,2 
0,4 7,4±0,6 2,4 7,9±0,1 2,9 8,5±0,3 3,5 
0,27 7,1±0,1 2,1 9,7±0,3 4,7 8,2±0,2 3,2 
0,13 6,6±0,1 1,6 8,0±0,3 3,0 8,0±0,6 3,0 
104c 
0,33 7,3±0,1 2,3   8,2±0,2 3,2 
0,26 7,3±0,1 2,3   8,1±0,4 3,1 
0,19 7,4±0,1 2,4   7,6±0,3 2,6 
0,13 7,2±0,3 2,2   7,1±0,1 2,1 
0,07 7,0±0,2 2,0   6,4±0,1 1,4 
83 
0,63 6,3±0,2 1,3   8,7±0,3 3,7 
0,5 7,5±0,1 2,5   7,4±0,3 2,4 
0,38 6,7±0,3 1,7   7,2±0,7 2,2 
0,25 6,6±0,1 1,6   6,9±0,1 1,9 
0,13 6,4±0,2 1,4   6,7±0,1 1,7 
110a 
0,77 8,9±0,5 3,9 8,2±0,4 3,2 7,8±0,4 2,8 
0,62 8,9±0,5 3,9   8,1±0,3 3,1 
0,46 8,8±0,5 3,8   7,6±0,1 2,6 
0,3 8,6±0,1 3,6   7,7±0,3 2,7 
0,15 8,3±0,4 3,3   7,4±0,2 2,4 
 
 
 
Figure. 1. The diameter of inhibition zone demonstrated by protein from isolate number 
D113a 
  
The graph number 1 shows that protein derived from isolate number D113a posses a 
minimum inhibitory concentration (MIC) against S aureus dan C albican of 0,19 μg/μl 
respectiely and against E coli of 0,38 μg/μl. Whereas, figure number 2 demonstrated that protein 
fermented from isolate number D94b has a minimum inhibitory concentration (MIC) against S 
aureus and C albican of 0,17 μg/μl respectively and against E coli of 0,85 μg/μl. 
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Figure. 2. The diameter of inhibition zone demonstrated by protein from isolate number 
D94b 
 
 
Figure. 3. The diameter of inhibition zone demonstrated by protein from isolate number 
D153 
 
The above figure demonstrates that the protein isolate number D153 has a minimum 
inhibitory concentration (MIC) against S aureus, E coli dan C albican of 0,13 μg/μl 
respectively. Meanwhile, the figure below number 4 shows that protein isolate number D104c 
has a minimum inhibitory concentration (MIC) against S aureus dan C albican of  0,07 μg/μl 
respectively but not against E coli . 
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Figure.4. The diameter of inhibition zone demonstrated by protein from isolate number 
D104c 
 
 
Figure.5. The diameter of inhibition zone demonstrated by protein from isolate number D83. 
 
The figure 5 above displays the activity of protein isolate number D83 against  S aureus 
and C albican, showing a minimum inhibitory concentration (MIC) of 0,13 μg/μl respectively 
but did not have potency as an antibacterial agent against  E coli. This figure 6 below shows that 
protein isolate number D110a has a minimum inhibitory concentration (MIC) against S aureus 
and C albican of 0,15 μg/μl respectively and against E coli of 0,77  μg/μl. 
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Figure.6. The diameter of inhibition zone demonstrated by protein from isolate number 
D110a. 
 
The protein was coagulated with ammonium sulfat and purified with dialysis before 
they were tested with SDS page.  
 
               
 
Figure 7. The results of SDS PAGE test on the protein derived from the 6 isolates  
 
Discussion  
The results showed different antimicrobial effect of each protein isolate against 
Eschericia coli, Staphylococcus aureus, and Candida albican. Protein isolated from six 
thermophilic bacteria have antimicrobial activity to Eschericia coli, Staphylococcus aureus, and 
Candida albican, except the isolates number 104c and 83, which have no antimicrobial activity 
against Eschericia coli. The antimicrobial capability of these extracellular protein is due to the 
presence of Antimicrobial Peptides (AMP) produced by a fermentation process of each isolates 
in NB medium with 1% glucose. Several studies had demonstrated that AMP, either in the form 
of synthetic or natural, is capable of improving the immunity sytem and therefore is considered 
as a poten antibiotic. The later effect is caused by a strong electrostatic bond between the 
negative charge of bacteria and the positive charge of AMP. When a critical concentration of 
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AMPs accumulate on the microbial surface, intercolation and assembly of their hydrophobic 
faces within the cytoplasmic membrane leads to formation of ion channels or aqueous pores, 
leading to microbial death through hypoosmotic lysis (Gutsmann et al., 2001; Oren et al., 1999). 
In bacteria, the principal site of AMP action is the cytoplasmic membrane, therefore the result is 
a disruption to the bacterial cell membrane.  
Almost AMP can kill either negative or positive gram Gram-positive bacteria lack an 
outer membrane, but possess a thick cell wall composed of  heavily crosslinked polymers of 
teichoic or lipoteichoic cids and peptidoglycan. Gram-negative bacteria do not produce teichoic 
acids, but have a multilayered surface structure including a peptidoglycan matrix in the 
periplasmic space beneath an outer membrane. This outer membrane contains the bound 
complex of lipid A, core polysaccharide and specific side-chain (O) polysaccharides known as 
lipopolysaccharide (LPS) (Nizet N, 2011). These antimicrobial effects are due to the ability to 
neutralize the lipopolysaccharide (LPS) therefore the extracellular protein ability against 
negative or protein gram bacteria was distinctive (Hoskin,  D. W. and Ramamoorthy, A., 2008). 
Furthermore, some bactericidal peptides have the cancer and anti viral activity due to their 
effects in improving the adaptive immune system 
On the other hand, some studies have shown that some peptides can cause cell death 
without significant membrane perturbation. Thus, it is proposed that CAMPs can be divided into 
two functional groups: membrane-disruptive and membrane-nondisruptive peptides (Powers & 
Hancock, 2003). However, this grouping is not completely clear, since peptides that attack 
membranes of some species may be membrane-nondisruptive in other species. Furthermore, 
many peptides have a multifunctional role, affecting both cell membranes as well as internal 
targets. Whatever the actual target of peptides, the ability to interact with lipid bilayers is crucial 
for their action. Whether the final target of a peptide is the cell membrane or some intracellular 
component, it has to find its way through the cell envelope (Yount et al., 2006).  
The mechanism of action of antifungal peptides involves  membrane 
permeabilization/translocation, inhibition of cellular processes and formation of reactive oxygen 
species (ROS) in the fungal species. AMPs have been known to translocate across the cell 
membrane and exert antimicrobial action by affecting macromolecular processes such as 
protein, nucleic acid and cell wall synthesis and enzyme activities. The formation of ROS has 
been suggested to play a pivotal role in the fungicidal activity of most of the antifungal peptides. 
(Pushpanathan M, et al., 2013). 
 
CONCLUSION AND SUGGESTION 
 
It can be concluded that almost protein derived from six isolated thermophilic bacteria 
demonstrate antimicrobial activity to Eschericia coli, Staphylococcus aureus, and Candida 
albican, except the ones isolated from thermophilic bacteria no 104c and 83, which have no 
antimicrobial effect to  Eschericia coli. Further studies are needed to explore the working 
mechanisms of these AMPs we found and to investigate the other potential effects.  
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